✦ LIBER ✦

5.30 Preliminary Results from a Phase I/II Study of Fludarabine (F), Rituximab (R), and Lenalidomide (L) in Untreated Patients with Chronic Lymphocytic Leukemia (CLL)

✍ Scribed by Ian W. Flinn; Ines M. Macias-Perez; Patrick S. Tucker; R. Seth Cooper; Habib H. Doss; Dana S. Thompson; Jesus G. Berdeja; John D. Hainsworth

Book ID: 119218974
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 95 KB
Volume: 11
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2011.09.184

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of lenalidomide in combi

A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL

✍ Brown, J R; Abramson, J; Hochberg, E; Mikler, E; Dalton, V; Werner, L; Reynolds, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 184 KB

5.28 Combining Fludarabine and Rituximab

5.28 Combining Fludarabine and Rituximab With Escalating Doses of Lenalidomide in Untreated Chronic Lymphocytic Leukemia: The REVLIRIT CLL5 AGMT Phase 1/2 Study—Results from Clinical and Exploratory Analyses of Induction

✍ A. Egle; M. Steurer; F. Gassner; R. Geisberger; T. Melchardt; L. Weiss; M. Fridr 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 89 KB

A phase I/II study of rituximab and etan

A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma

✍ Lin, T S; Lucas, M S; Heerema, N; Moran, M E; Cheney, C; Woyach, J A; Lucas, D M 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 160 KB

Bendamustine in Combination With Rituxim

Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Bottcher, S.; Bahlo, J.; Schubert, J.; Pflug 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 156 KB

Lenalidomide and Rituximab for the Initi

Lenalidomide and Rituximab for the Initial Treatment of Patients With Chronic Lymphocytic Leukemia: A Multicenter Clinical-Translational Study From the Chronic Lymphocytic Leukemia Research Consortium

✍ James, D. F.; Werner, L.; Brown, J. R.; Wierda, W. G.; Barrientos, J. C.; Castro 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 576 KB

5.40 Rituximab Maintenance in Patients w

5.40 Rituximab Maintenance in Patients with Chronic Lymphocytic Leukemia after First-Line Treatment with Rituximab plus Fludarabine, Cyclophosphamide, and Mitoxantrone: Final Results of a Multicenter Phase II Trial on Behalf of the Spanish CLL Study Group (GELLC)

✍ Francesc Bosch; Pau Abrisqueta; Neus Villamor; María José Terol; Eva González-Ba 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 250 KB